{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:48:47Z","timestamp":1769550527477,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.mehy.2020.110434","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T02:13:31Z","timestamp":1606356811000},"page":"110434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Can chloroquine\/hydroxychloroquine prove efficient in cancer cachexia? A hypothesis in the era of COVID-19"],"prefix":"10.1016","volume":"146","author":[{"given":"Miroslaw","family":"Kiedrowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemyslaw","family":"Kapala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlena","family":"Kiedrowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Skoczynska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Czerw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Depta\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mehy.2020.110434_b0005","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jcsm.12528","article-title":"Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia","volume":"11","author":"Peixoto da Silva","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"11","key":"10.1016\/j.mehy.2020.110434_b0010","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1172\/JCI36389","article-title":"Evidence that cytokines play a role in rheumatoid arthritis","volume":"118","author":"Brennan","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2020.110434_b0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.gene.2018.05.041","article-title":"The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry","volume":"668","author":"Goulielmos","year":"2018","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.mehy.2020.110434_b0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.mehy.2020.110434_b0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.mehy.2020.110434_b0030","article-title":"Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial","author":"Chen","year":"2020","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.mehy.2020.110434_b0035","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.mehy.2020.110434_b0040","first-page":"215","article-title":"A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19","volume":"49","author":"Chen","year":"2020","journal-title":"J Zhejiang Univ (Med Sci)"},{"issue":"6","key":"10.1016\/j.mehy.2020.110434_b0045","doi-asserted-by":"crossref","first-page":"105982","DOI":"10.1016\/j.ijantimicag.2020.105982","article-title":"Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies","volume":"55","author":"Zhao","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"1 Pt 2","key":"10.1016\/j.mehy.2020.110434_b0050","first-page":"1216","article-title":"Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1","volume":"25","author":"Ferrara","year":"1993","journal-title":"Transplant Proc."},{"key":"10.1016\/j.mehy.2020.110434_b0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"10.1016\/j.mehy.2020.110434_b0060","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.mehy.2020.110434_b0065","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1200\/JOP.2016.016832","article-title":"Cancer cachexia: beyond weight loss","volume":"12","author":"Bruggeman","year":"2016","journal-title":"J Oncol Pract"},{"issue":"4","key":"10.1016\/j.mehy.2020.110434_b0070","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/SPC.0b013e3283311c6f","article-title":"An update on promising agents for the treatment of cancer cachexia:","volume":"3","author":"Madeddu","year":"2009","journal-title":"Curr Opin Supportive Palliative Care"},{"issue":"8","key":"10.1016\/j.mehy.2020.110434_b0075","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1517\/14656560902960162","article-title":"Medroxyprogesterone acetate in the management of cancer cachexia","volume":"10","author":"Madeddu","year":"2009","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1016\/j.mehy.2020.110434_b0080","first-page":"181","article-title":"Cancer cachexia and immunomodulation","volume":"10","author":"Myrianthefs","year":"2005","journal-title":"J Buon"},{"issue":"10","key":"10.1016\/j.mehy.2020.110434_b0085","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1200\/JCO.1999.17.10.3299","article-title":"Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia\/cachexia","volume":"17","author":"Loprinzi","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.mehy.2020.110434_b0090","doi-asserted-by":"crossref","unstructured":"Dewey A, Baughan C, Dean T, Higgins B, Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev. 2007;2007(1):CD004597. Published 2007 Jan 24. doi:10.1002\/14651858.CD004597.pub2.","DOI":"10.1002\/14651858.CD004597.pub2"},{"issue":"5","key":"10.1016\/j.mehy.2020.110434_b0095","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","article-title":"Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases","volume":"23","author":"Rainsford","year":"2015","journal-title":"Inflammopharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2020.110434_b0100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1534-5807(04)00099-1","article-title":"Development by self-digestion","volume":"6","author":"Levine","year":"2004","journal-title":"Dev Cell"},{"key":"10.1016\/j.mehy.2020.110434_b0105","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","article-title":"Autophagy as a regulated pathway of cellular degradation","volume":"290","author":"Klionsky","year":"2000","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.mehy.2020.110434_b0110","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.mehy.2020.110434_b0115","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","article-title":"Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion","volume":"14","author":"Mauthe","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.mehy.2020.110434_b0120","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fonc.2018.00335","article-title":"Re-purposing chloroquine for glioblastoma: potential merits and confounding variables","volume":"8","author":"Weyerh\u00e4user","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.mehy.2020.110434_b0125","doi-asserted-by":"crossref","unstructured":"Liu T, Zhang J, Li K, et al. Combination of an autophagy inducer and an autophagy Inhibitor: a smarter strategy emerging in cancer therapy. Front Pharmacol 2020;11:408. doi: 10.3389\/fphar.2020.00408.","DOI":"10.3389\/fphar.2020.00408"},{"issue":"3","key":"10.1016\/j.mehy.2020.110434_b0130","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4161\/auto.6.3.11625","article-title":"Targeting the pro-death and pro-survival functions of autophagy as novel therapeutic strategies in cancer","volume":"6","author":"Dalby","year":"2010","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.mehy.2020.110434_b0135","doi-asserted-by":"crossref","first-page":"e29911","DOI":"10.4161\/mco.29911","article-title":"Chloroquine and hydroxychloroquine for cancer therapy","volume":"1","author":"Manic","year":"2014","journal-title":"Mol Cell Oncol"},{"key":"10.1016\/j.mehy.2020.110434_b0140","doi-asserted-by":"crossref","unstructured":"Wang F, Tang J, Li P, et al. Chloroquine enhances the radiosensitivity of bladder cancer cells by inhibiting autophagy and activating apoptosis. Cell Physiol Biochem 2018;45(1):54\u201366. doi: 10.1159\/000486222.","DOI":"10.1159\/000486222"},{"key":"10.1016\/j.mehy.2020.110434_b0145","unstructured":"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or Accessed: 12th of November, 2020."},{"key":"10.1016\/j.mehy.2020.110434_b0150","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/results?cond=Covid19&term=chloroquine&cntry=&state=&city=&dist Accessed 12th of November, 2020."},{"issue":"7","key":"10.1016\/j.mehy.2020.110434_b0155","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"58","author":"Henry","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.mehy.2020.110434_b0160","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.medmal.2020.04.002","article-title":"Interleukin-6 as a potential biomarker of COVID-19 progression","volume":"50","author":"Ulhaq","year":"2020","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.mehy.2020.110434_b0165","doi-asserted-by":"crossref","unstructured":"Fiorino G, Allocca M, Furfaro F, et al. Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience [published online ahead of print, 2020 Mar 24]. J Crohns Colitis. 2020;jjaa058. doi:10.1093\/ecco-jcc\/jjaa058.","DOI":"10.1093\/ecco-jcc\/jjaa058"},{"key":"10.1016\/j.mehy.2020.110434_b0170","first-page":"E005","article-title":"Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia","volume":"43","author":"Chen","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"3","key":"10.1016\/j.mehy.2020.110434_b0175","doi-asserted-by":"crossref","first-page":"398.1","DOI":"10.3899\/jrheum.161063","article-title":"Increased incidence of gastrointestinal side effects in patients taking hydroxychloroquine: a brand-related issue?","volume":"44","author":"Srinivasa","year":"2017","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.mehy.2020.110434_b0180","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00408-020-00323-8","article-title":"Ranking self-reported gastrointestinal side effects of pharmacotherapy in sarcoidosis","volume":"198","author":"Drent","year":"2020","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.mehy.2020.110434_b0185","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/1529-0131(199902)42:2<357::AID-ANR19>3.0.CO;2-J","article-title":"Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension","volume":"42","author":"Furst","year":"1999","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.mehy.2020.110434_b0190","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41584-018-0111-8","article-title":"Hydroxychloroquine retinopathy\u2014implications of research advances for rheumatology care","volume":"14","author":"Jorge","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.mehy.2020.110434_b0195","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.mehy.2020.110434_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2009\/693458","article-title":"Estimation of cachexia among cancer patients based on four definitions","volume":"2009","author":"Fox","year":"2009","journal-title":"J Oncol"},{"issue":"2","key":"10.1016\/j.mehy.2020.110434_b0205","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.mehy.2020.110434_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2018.07.010","article-title":"Platinum-induced muscle wasting in cancer chemotherapy: mechanisms and potential targets for therapeutic intervention","volume":"208","author":"Moreira-Pais","year":"2018","journal-title":"Life Sci"},{"issue":"11","key":"10.1016\/j.mehy.2020.110434_b0215","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720333259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720333259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:26:57Z","timestamp":1759692417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720333259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":43,"alternative-id":["S0306987720333259"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110434","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can chloroquine\/hydroxychloroquine prove efficient in cancer cachexia? A hypothesis in the era of COVID-19","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110434"}}